Table 5.
Variable | Bivariate | Multivariate | ||||
---|---|---|---|---|---|---|
HR [exp(β)] | 95% CI | p-value* | HR [exp(β)] | 95% CI | p-value* | |
Graft Survival |
||||||
DCD | 2.45 | 1.35–4.44 | 0.007 | 2.64 | 1.43–4.88 | 0.002 |
Recipient age (per 10 years) | 1.25 | 0.97–1.62 | 0.09 | 1.35 | 1.04–1.75 | 0.02 |
Recipient race/ethnicity | ||||||
White (reference) | 1.00 | NA | NA | 1.00 | NA | NA |
African-American | 2.06 | 0.97–4.37 | 0.06 | 2.19 | 0.99–4.81 | 0.051 |
Other (hispanic and asian) | 0.86 | 0.31–2.39 | 0.78 | 0.65 | 0.24–1.82 | 0.42 |
Hepatocelluar carcinoma | 0.62 | 0.36–1.07 | 0.08 | 0.60 | 0.30–1.22 | 0.16 |
MELD (calculated) | 1.02 | 0.96–1.04 | 0.10 | 1.004 | 0.97–1.04 | 0.81 |
Patient Survival** |
||||||
DCD | 1.86 | 0.86–4.01 | 0.12 | 1.75 | 0.80–3.84 | 0.17 |
Recipient age (per 10 years) | 1.39 | 1.006–1.92 | 0.05 | 1.50 | 1.09–2.06 | 0.01 |
Recipient race/ethnicity | ||||||
White (reference) | 1.00 | NA | NA | 1.00 | NA | NA |
Afrincan-American | 1.15 | 0.41–3.24 | 0.79 | 0.99 | 0.34–2.87 | 0.99 |
Other (hispanic and asian) | 0.41 | 0.10–1.72 | 0.23 | 0.43 | 0.10–1.78 | 0.24 |
Hepatocelluar carcinoma | 0.70 | 0.36–1.35 | 0.28 | 0.90 | 0.39–2.10 | 0.81 |
MELD (calculated)*** | 1.03 | 1.00–1.06 | 0.05 | 1.03 | 0.99–1.07 | 0.10 |
In bivariate analysis, p-value <0.10 was considered significant; p<0.05 significant in multivariate model.
Patient survival adjusted according to same multivariate model applied to graft survival.
Hazard ratios reported per unit increase in MELD score.